Alpha Rose Therapeutics, born from a father's love for his daughter, is pioneering personalized medicine at scale for children with genetic diseases. Our innovative approach rapidly develops and commercializes treatments for patients ignored by large pharma. With over $1 million in funding, our lead product, Rosiphersen, is advancing towards a clinical trial, backed by the NCATS TRND program acceptance and led by a passionate, experienced team. AlphaRose Therapeutics is an early-stage biotechnology company, and its treatments, including Rosiphersen, are still in development and have not yet been approved for clinical use.

Raised

$1.6M

Post-money

$13.8M

Rounds

EndoSound

Biotech

Operating

Driving access to high-impact endoscopic ultrasound

Health Care Originals

Healthcare

Operating

AI-powered respiratory care for asthma & copd patients

Immigrant-foundedWoman-foundedMinority-founded

Delee

Biotech

Operating

Blood testing device for early diagnosis of cancer and treatment monitoring

Minority-foundedWoman-founded

RATD Productions LLC

Media & Entertainment

AppMail

Sports & Recreation

Operating

The next-generation interactive email

Atmos Home

Industrial & Manufacturing

Operating

Simplifying the Smart Home

Boaz Bikes

Industrial & Manufacturing · Engineering

Operating

Electric shared scooter company that is focused on SAFETY!

OK Stone Engineering, Inc.

Industrial & Manufacturing

ElliptiGO

Sports & Recreation

Operating

Own a piece of ElliptiGO, the leading provider of elliptical and stand-up bicycles around the world. This is your chance to invest in the next big category of outdoor fitness and recreation with an established company that has already generated more than $45 million in sales.